Izen Biosciences Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
- Paid Up Capital ₹ 6.50 Cr
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2015
- Satisfied Charges ₹ 7.24 Cr
About Izen Biosciences
Izen Biosciences Private Limited (IBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 April 2011 and has a history of 13 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 6.50 Cr.
The company has closed loans amounting to ₹7.24 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
John Kuchentungu, Ramkumar Vishnubhotla, Sree Volety, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TG2011PTC074011
- Company No.
074011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2011
- Date of AGM
26 Jun 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Izen Biosciences Private Limited offer?
Izen Biosciences Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Business Planning and Management, Business Consultant, Material Testing Labs & Services, Laboratory Testing Services, Copyright & Trademark, Trademarks Services.
Who are the key members and board of directors at Izen Biosciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
John Kuchentungu  | Director | 22-Apr-2011 | Current |
| Sree Volety | Director | 07-Nov-2017 | Current |
| Ramkumar Vishnubhotla | Director | 01-Nov-2018 | Current |
Dr Michael  | Additional Director | 16-Aug-2012 | Current |
Financial Performance of Izen Biosciences.
Izen Biosciences Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Izen Biosciences?
In 2015, Izen Biosciences had a promoter holding of 8.32% and a public holding of 91.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
G3 Tech Business Private LimitedRamkumar Vishnubhotla is a mutual person
Charges (Loans)
₹0
₹7.24 Cr
Charges Breakdown by Lending Institutions
- Dena Bank : 5.84 Cr
- State Bank Of India : 1.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2013 | Dena Bank | ₹5.84 Cr | Satisfied |
| 14 Feb 2012 | State Bank Of India | ₹1.40 Cr | Satisfied |
How Many Employees Work at Izen Biosciences?
Unlock and access historical data on people associated with Izen Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Izen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Izen Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
